日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

CX-5461 针对富含 DNA 修复缺陷的晚期实体瘤患者的 I 期 CCTG IND.231 试验结果

John Hilton #, Karen Gelmon #, Philippe L Bedard, Dongsheng Tu, Hong Xu, Anna V Tinker, Rachel Goodwin, Scott A Laurie, Derek Jonker, Aaron R Hansen, Zachary W Veitch, Daniel J Renouf, Linda Hagerman, Hongbo Lui, Bingshu Chen, Deb Kellar, Irene Li, Sung-Eun Lee, Takako Kono, Brian Y C Cheng, Damian

Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma

未分化和去分化子宫内膜癌的治疗和结局

Sarah Nicole Hamilton, Anna V Tinker, Janice Kwon, Peter Lim, Iwa Kong, Sona Sihra, Martin Koebel, Cheng Han Lee

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

帕博利珠单抗联合低剂量卡铂治疗复发性铂耐药卵巢癌、输卵管癌和原发性腹膜癌:生存率和免疫相关性

John B Liao ,William R Gwin ,Renata R Urban ,Katie M Hitchcock-Bernhardt ,Andrew L Coveler ,Doreen M Higgins ,Jennifer S Childs ,Hania N Shakalia ,Ron E Swensen ,Sasha E Stanton ,Anna V Tinker ,Tanya A Wahl ,Richard G Ancheta ,Kathryn F McGonigle ,James Y Dai ,Mary L Disis ,Barbara A Goff

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

恢复 RAD51C 和 RAD51D 的继发性体细胞突变与高级别卵巢癌对 PARP 抑制剂 Rucaparib 的获得性耐药性有关

Olga Kondrashova, Minh Nguyen, Kristy Shield-Artin, Anna V Tinker, Nelson N H Teng, Maria I Harrell, Michael J Kuiper, Gwo-Yaw Ho, Holly Barker, Maria Jasin, Rohit Prakash, Elizabeth M Kass, Meghan R Sullivan, Gregory J Brunette, Kara A Bernstein, Robert L Coleman, Anne Floquet, Michael Friedlander,

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

细胞系和患者来源的异种移植模型表明 CDCP1 升高是高级别浆液性卵巢癌的靶点

Brittney S Harrington, Yaowu He, Claire M Davies, Sarah J Wallace, Mark N Adams, Elizabeth A Beaven, Deborah K Roche, Catherine Kennedy, Naven P Chetty, Alexander J Crandon, Christopher Flatley, Niara B Oliveira, Catherine M Shannon, Anna deFazio, Anna V Tinker, C Blake Gilks, Brian Gabrielli, Donal